ArticleTargeted oncology2023

Results from a Real-World Multicenter Analysis of 482 Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib: A Look at Racial Differences.

Jacqueline C Barrientos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.